Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May;37(3):406-411.
doi: 10.1111/pde.14215. Epub 2020 May 22.

Chilblains in children in the setting of COVID-19 pandemic

Affiliations

Chilblains in children in the setting of COVID-19 pandemic

David Andina et al. Pediatr Dermatol. 2020 May.

Abstract

Background: Different skin manifestations of COVID-19 are being reported. Acral lesions on the hands and feet, closely resembling chilblains, have been recognized during the peak incidence of the COVID-19 pandemic.

Material and methods: A retrospective review of 22 children and adolescents with chilblain-like lesions seen over a short period of time in the Emergency Department of a children's hospital during the peak incidence of COVID-19 in Madrid, Spain.

Results: All patients had lesions clinically consistent with chilblains of the toes or feet, with three also having lesions of the fingers. Pruritus and mild pain were the only skin symptoms elicited, and only 10 had mild respiratory and/or GI symptoms. None had fever. Coagulation tests, hemogram, serum chemistry, and lupus anticoagulant were normal in all patients tested. One out of 16 tested cases had elevated D-dimer results, but without systemic symptoms or other laboratory anomalies. SARS-CoV-2 PCR tested in 19 cases was positive in just one case. Skin biopsies obtained in six patients were consistent with chilblains. On follow-up, all cases showed spontaneous marked improvement or complete healing.

Conclusion: Acute chilblains were observed during COVID-19 pandemic in children and teenagers. It is a mildly symptomatic condition with an excellent prognosis, usually requiring no therapy. Etiopathogenesis remains unknown.

Keywords: COVID-19; SARS-CoV-2; acral ischemia; chilblain; dermoscopy; pernio; skin.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
A‐D, Clinical spectrum of chilblains in four patients in the series
FIGURE 2
FIGURE 2
Dermoscopic features. A, Violaceous erythema, purpuric dots, and subungual hyperpigmentation. B, Erythema, vasodilatation, and purpuric dots
FIGURE 3
FIGURE 3
A, Dense, superficial, and deep angiocentric and eccrinotropic lymphocytic infiltrate (H&E stain, 10×). B, Papillary dermal edema, vacuolar degeneration of the basal layer and lymphocytic exocytosis. Endothelia of small vessels appear swollen (H&E stain, 20×). C, Intense lymphocytic vascular reaction in dermal vessels (H&E stain, 40×). D, Red cell extravasation and focal thrombosis (arrow) in papillary dermis capillaries (H&E stain, 100×)

References

    1. Recalcati S. Cutaneous manifestations in COVID‐19: a first perspective. J Eur Acad Dermatol Venereol. 2020. 10.1111/jdv.16387 Epub ahead of print. - DOI - PubMed
    1. Mahé A, Birckel E, Krieger S, Merklen C, Bottlaender L. A distinctive skin rash associated with Coronavirus Disease 2019? J Eur Acad Dermatol Venereol. 2020. 10.1111/jdv.16471 Epub ahead of print. - DOI - PMC - PubMed
    1. Marzano AV, Genovese G, Fabbrocini G, et al. Varicella‐like exanthem as a specific COVID‐19‐associated skin manifestation: multicenter case series of 22 patients. J Am Acad Dermatol. 2020;S0190‐9622(20)30657‐5. 10.1016/j.jaad.2020.04.044 Epub ahead of print. - DOI - PMC - PubMed
    1. Henry D, Ackerman M, Sancelme E, Finon A, Esteve E. Urticarial eruption in COVID‐19 infection. J Eur Acad Dermatol Venereol. 2020. 10.1111/jdv.16472 Epub ahead of print. - DOI - PMC - PubMed
    1. Manalo IF, Smith MK, Cheeley J, Jacobs R. A dermatologic manifestation of COVID‐19: transient livedo reticularis. J Am Acad Dermatol. 2020;S0190‐9622(20)30558‐2. 10.1016/j.jaad.2020.04.018 Epub ahead of print. - DOI - PMC - PubMed

MeSH terms